Stock conversion ratio Redeemable Non Controlling Interest Exchange Agreement Stock Conversion Ratio Redeemable non controlling interest exchange agreement stock conversion ratio. vTv Therapeutics LLC V Tv L L C [Member] vTv LLC. Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Total lease payments Lessee, Operating Lease, Liability, to be Paid Net loss before noncontrolling interest Net loss before noncontrolling interest Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Related Party Transactions [Abstract] Related Party Transactions [Abstract] License Agreement Obligations License Agreement Obligations [Domain] License agreement obligations. Entity Address, Postal Zip Code Entity Address, Postal Zip Code Non-cash interest income Interest Income, Operating Revenue from Contract with Customer [Roll Forward] Change in Contract with Customer, Liability [Roll Forward] Change in Contract with Customer, Liability Change in redemption value of noncontrolling interest Noncontrolling Interest, Change in Redemption Value Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Equity investment with readily determinable fair value: Equity Investments With Readily Determinable Fair Value Equity investments with readily determinable fair value. Collaborative arrangement, contingent consideration Collaborative Arrangement, Contingent Consideration Transferred, Aggregate Share Value Collaborative Arrangement, Contingent Consideration Transferred, Aggregate Share Value (Increase) in vTv Therapeutics Inc. accumulated deficit for purchase of LLC Units as a result of common stock issuances Consolidation Changes Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent Consolidation changes wholly owned subsidiary parent ownership interest changes purchase of interest by parent. Financial Instruments Financial Instruments [Domain] CinRx CinRx [Member] CinRx Stock options cancelled (in shares) Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled. Statistical Measurement Statistical Measurement [Domain] Depreciation expense Depreciation Proceeds from debt issuance Proceeds from Issuance of Debt Exercise of stock options, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period MacAndrews & Forbes Incorporated Mac Andrews And Forbes Incorporated [Member] MacAndrews and Forbes Incorporated. Weighted average incremental borrowing rate Operating Lease, Weighted Average Discount Rate, Percent Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Additional paid-in capital Additional Paid in Capital, Common Stock Type 2 Diabetes Type Two Diabetes [Member] Type 2 diabetes. Lessee, operating lease, termination period Lessee, Operating Lease, Termination Period Lessee, Operating Lease, Termination Period G2 Investment G2 Investment [Member] G2 Investment Organization Consolidation And Presentation Of Financial Statements [Line Items] Organization Consolidation And Presentation Of Financial Statements [Line Items] Organization consolidation and presentation of financial statements. Net loss attributable to vTv Therapeutics Inc. Net loss Net Income (Loss) Attributable to Parent Measurement Input Type Measurement Input Type [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Potentially dilutive securities not included in calculation of dilutive net loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Document Information [Line Items] Document Information [Line Items] Receivables from Stockholder Receivables from Stockholder [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Lessee, Operating Lease, Liability, Payment, Due [Abstract] Lessee, Operating Lease, Liability, to be Paid [Abstract] Equity Component Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Equity securities with readily determinable fair value - Total Assets, Fair Value Disclosure Leases Lessee, Operating Leases [Text Block] Investment, Name [Domain] Investment, Name [Domain] Related Party Related Party [Domain] Variable Interests And Equity Method Investments Disclosure [Abstract] Variable Interests And Equity Method Investments Disclosure [Abstract] Variable Interests And Equity Method Investments Disclosure [Abstract] Funding received Funding Received Funding received. Expected dividend yield Measurement Input, Expected Dividend Rate [Member] Forfeited (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Noncontrolling Interest [Abstract] Noncontrolling Interest [Abstract] 2022 (remaining three months) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Proceeds from sale of Class A common stock to collaboration partner, net of offering costs Proceeds From Sale Of Common Stock Proceeds From Sale Of Common Stock Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Common stock, value Common Stock, Value, Outstanding Entity Address, State or Province Entity Address, State or Province Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Cantor Fitzgerald Cantor Fitzgerald [Member] Cantor fitzgerald member. Award Type Award Type [Axis] Novo License Agreement Novo License Agreement [Member] Novo license agreement. Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Current portion of operating lease liabilities Operating Lease, Liability, Current Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Related Party Transaction [Domain] Related Party Transaction [Domain] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Redeemable Noncontrolling Interest Redeemable Noncontrolling Interests [Member] Redeemable noncontrolling interests. Transaction Transaction [Domain] Phase 2 MRCT Phase Two Multi Regional Clinical Trial [Member] Phase two multi-regional clinical trial. Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Other Commitments Other Commitments [Domain] Liability Class [Axis] Liability Class [Axis] Legal Entity Legal Entity [Axis] Promissory note receivable for common stock Stockholders' Equity Note, Subscriptions Receivable Total liabilities Liabilities Remaining operating lease term Operating Lease, Weighted Average Remaining Lease Term Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Issuance of Class A common stock to collaboration partner, net of offering cost Stock issued during period Stock Issued During Period, Value, New Issues Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Document Type Document Type Stock Conversion Description Stock Conversion Description [Axis] Concentration Risk Benchmark Concentration Risk Benchmark [Domain] Equity Securities Without Readily Determinable Fair Value [Line Items] Equity Securities without Readily Determinable Fair Value [Line Items] Redemption amount of noncontrolling interest Redeemable Noncontrolling Interest Temporary Equity Redemption Value Redeemable noncontrolling interest temporary equity redemption value. Product and Service Product and Service [Domain] Entity Shell Company Entity Shell Company Class B Common Stock Common Class B [Member] Net Change in fair value included in earnings Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Commitment Contingency And Related Party Transactions [Abstract] Commitment Contingency And Related Party Transactions [Abstract] Commitment, Contingency And Related Party Transactions [Abstract] Financial Instrument Financial Instrument [Axis] Affiliated Entity Affiliated Entity [Member] Subsequent Event Subsequent Event [Member] Revenue Revenue Benchmark [Member] Summary of Contract Liabilities Related to Company's Collaboration Agreements Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Document Period End Date Document Period End Date Sale of stock, consideration received on transaction, gross Sale of Stock, Consideration Received on Transaction, Gross Sale of Stock, Consideration Received on Transaction, Gross Total assets Assets Earnings Per Share [Abstract] Earnings Per Share [Abstract] Income Statement Location Income Statement Location [Axis] Assets: Equity Securities, FV-NI, Current Antidilutive Securities Antidilutive Securities [Axis] Change in redemption value of noncontrolling interest Temporary Equity, Change In Redemption Value Temporary Equity, Change In Redemption Value Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Accounting Policies [Abstract] Long-term investments Long-Term Investments Other Commitments Other Commitments [Axis] Loss before income taxes and noncontrolling interest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Stockholders’ deficit: Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Net Loss per Share Earnings Per Share [Text Block] Redeemable Noncontrolling Interest Noncontrolling Interest Disclosure [Text Block] Customer [Axis] Customer [Axis] Commitments And Contingencies [Line Items] Commitments And Contingencies [Line Items] Commitments and Contingencies. CinRx Warrants CinRx Warrants [Member] CinRx Warrants Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Award Type Award Type [Domain] Number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Weighted average period to recognize unrecognized share-based compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Options exercisable, weighted average remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Anteris Bio Inc Anteris Bio Inc [Member] Anteris Bio, Inc. Entity Registrant Name Entity Registrant Name Amount of cash savings percentage Percentage Of Amount Of Cash Savings Percentage of amount of cash savings. Collaborate arrangement, contingent consideration transferred, cash Collaborate Arrangement, Contingent Consideration Transferred, Cash Collaborate Arrangement, Contingent Consideration Transferred, Cash Issuance of Class A Common Stock to Collaboration Partner (in shares) Stock Issued During Period, Shares, New Issues Collaboration Partner Collaboration Partner [Member] Collaboration Partner Type 1 Diabetes Type One Diabetes [Member] Type 1 diabetes. Subsequent Events Subsequent Events [Text Block] Research and Development Arrangement, Contract to Perform for Others, Type Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Entity Address, City or Town Entity Address, City or Town ATM Offering At The Market Offering [Member] At the market offering. G42 Investments G42 Investments [Member] G42 Investments Leases [Abstract] Leases [Abstract] Income Taxes [Table] Income Taxes [Table] Income taxes. Operating expenses: Operating Expenses [Abstract] Schedule Of Earnings Per Share [Line Items] Schedule Of Earnings Per Share [Line Items] Schedule Of Earnings Per Share [Line Items] Minimum Minimum [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common stock par value (in usd per share) Common Stock, Par or Stated Value Per Share Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Investment, Name [Axis] Investment, Name [Axis] Share price (usd per share) Share Price Trading Symbol Trading Symbol Entity File Number Entity File Number Contract liabilities, net of current portion Contract with Customer, Liability, Noncurrent Research and development Research and Development Expense Transaction Type Transaction Type [Axis] Options vested and expected to vest, weighted average remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Issuance of Class A Common Stock under LPC Agreement Stock Issued During Period, Value, Purchase Agreement Stock Issued During Period, Value, Purchase Agreement Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Title of Individual Title of Individual [Axis] Concentration Risk Benchmark Concentration Risk Benchmark [Axis] Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Use of Estimates Use of Estimates, Policy [Policy Text Block] Warrant liability, related party Due to Related Parties, Noncurrent Beginning Balance Ending Balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Concentration risk percentage Concentration Risk, Percentage Subsequent Events [Abstract] Subsequent Events [Abstract] Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Income Taxes Income Tax Disclosure [Text Block] Exercise price of warrants or rights (in usd per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Net loss per share of vTv Therapeutics Inc. Class A Common Stock, basic (in usd per share) Earnings Per Share, Basic CinRx Pharma, LLC CinRx Pharma, LLC [Member] CinRx Pharma, LLC Issuance Of Class A Common Stock Under ATM Offering (in shares) Issuance Of Class A Common Stock Under ATM Offering Issuance Of Class A Common Stock Under ATM Offering 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Award requisite service period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Consideration receivable, payment period Sale Of Stock, Consideration Receivable, Payment Period Sale Of Stock, Consideration Receivable, Payment Period Concentration Risk Type Concentration Risk Type [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Total stockholders’ deficit attributable to vTv Therapeutics Inc. Beginning balance Ending balance Stockholders' Equity Attributable to Parent Organization Consolidation And Presentation Of Financial Statements [Table] Organization Consolidation And Presentation Of Financial Statements [Table] Organization Consolidation And Presentation Of Financial Statements [Table] Proceeds from sale of Class A common stock and warrants, net of offering costs Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants Number of days used to determine exchange value based on weighted average price of Class A common stock Period Used To Determine Exchange Value Based On Weighted Average Price Of Class Common Stock Period used to determine exchange value based on weighted average price of Class A common stock. Newsoara Biopharma Co Ltd Newsoara Biopharma Co Ltd [Member] Newsoara Biopharma Co Ltd. Entity Interactive Data Current Entity Interactive Data Current Noncontrolling Interest [Line Items] Noncontrolling Interest [Line Items] Shares sold (in shares) Sale of Stock, Number of Shares Issued in Transaction Less: imputed interest Operating Leases Imputed Interest Operating leases imputed interest. Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Numerator: Net Income (Loss) Attributable to Parent [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Accumulated Deficit Retained Earnings [Member] Unrecognized compensation cost related to non-vested share-based compensation arrangements Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount JDRF J D R F International [Member] JDRF international. Common Stock Common Stock [Member] Summary of Compensation Expense Related to Grants of Stock Options Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Class of Stock Class of Stock [Axis] Statement [Table] Statement [Table] Summary of Net Income Attributable to Vtv Therapeutics Inc Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block] Lessee, operating lease, renewal term Lessee, Operating Lease, Renewal Term Document Quarterly Report Document Quarterly Report Current assets: Assets, Current [Abstract] Operating lease liabilities, net of current portion Operating Lease, Liability, Noncurrent Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Statistical Measurement Statistical Measurement [Axis] Related Party Transaction [Axis] Related Party Transaction [Axis] Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Equity Components Equity Components [Axis] M&F TTP Holdings LLC M F T T P Holdings L L C [Member] M&F TTP Holdings LLC. Fair Value, Measurements, Recurring Fair Value, Recurring [Member] Options exercisable (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Related-Party Transactions Related Party Transactions Disclosure [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Warrants, term Expected life of options in years Warrants and Rights Outstanding, Term Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Potential milestone payment Potential Milestone Payment Potential milestone payment. Receivables, fair value disclosure Receivables, Fair Value Disclosure Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Equity method investments, ownership percentage Investment Ownership Percentage Investment ownership percentage. Schedule of Equity Investments with and without Readily Determinable Fair Values Assessed Equity Securities With And Without Readily Determinable Fair Value Table [Table Text Block] Tabular disclosure of investment in equity security with and without readily determinable fair value. Fair Value Of Assets And Liabilities Measured On Recurring Basis [Table] Fair Value Of Assets And Liabilities Measured On Recurring Basis [Table] Fair value of assets and liabilities measured on recurring basis table. Document Transition Report Document Transition Report Local Phone Number Local Phone Number Summary of Stock Award Activity for the Period Share-Based Payment Arrangement, Option, Activity [Table Text Block] Operating loss Operating Income (Loss) Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Equity investment without readily determinable fair values assessed under the measurement alternative: Equity Securities without Readily Determinable Fair Value, Amount Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Document Information [Table] Document Information [Table] Common stock, shares outstanding (in shares) Beginning balance, shares (in shares) Ending balance, shares (in shares) Common Stock, Shares, Outstanding Potential development and regulatory milestone payments Potential Development And Regulatory Milestone Payments Receivable Potential development and regulatory milestone payments receivable. Liabilities: Liabilities, Fair Value Disclosure Adjustments to reconcile net loss before noncontrolling interest to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Income tax provision Income Tax Expense (Benefit) Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Income Statement [Abstract] Income Statement [Abstract] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Additional Paid-in Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Satisfaction of Milestone Payment Satisfaction Of Milestone Payment [Member] Satisfaction of milestone payment. Discount on note receivable Collaborative Arrangement, Note Receivable, Discount Paid Collaborative Arrangement, Note Receivable, Discount Paid Income Taxes [Line Items] Income Taxes [Line Items] Income taxes. Weighted-average number of vTv Therapeutics Inc. Class A Common Stock, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Issuance of class A common stock under LPC agreement, shares (in shares) Stock Issued During Period, Shares, Purchase Agreement Issuance of Class A Common Stock under LPC agreement shares.. Fair Value Of Assets And Liabilities Measured On Recurring Basis [Line Items] Fair Value Of Assets And Liabilities Measured On Recurring Basis [Line Items] Fair value of assets and liabilities measured on recurring basis. Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Current portion of notes payable Notes Payable, Current Collaborative Arrangements Collaborative Arrangement [Member] Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current Common stock value Common Stock, Value, Issued Preferred Stock Preferred Stock [Member] Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Change in fair value of warrants, related party Change In Fair Value Of Warrants Related Party Change in fair value of warrants related party. Summarizes the Conclusions Reached Regarding Fair Value Measurements Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Total cash, cash equivalents and restricted cash and cash equivalents, beginning of period Total cash, cash equivalents and restricted cash and cash equivalents, end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Less: net loss attributable to noncontrolling interest Less: Net loss attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Inputs utilized in the valuation of warrants Warrants and Rights Outstanding, Measurement Input Current liabilities: Liabilities, Current [Abstract] Proceeds from exercise of stock options Proceeds from Stock Options Exercised Net loss attributable to vTv Therapeutics Inc. common shareholders Net loss attributable to common shareholders of vTv Therapeutics Inc., basic Net Income (Loss) Available to Common Stockholders, Basic CinRx Investment CinRx Investment [Member] CinRx Investment Purchases / Issuance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Current portion of contract liabilities Contract with Customer, Liability, Current Warrants, fair value Warrants and Rights Outstanding Income Statement Location Income Statement Location [Domain] Interest expense Interest Expense, Other Amendment Flag Amendment Flag Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Developmental and Regulatory Milestone Payment Developmental And Regulatory Milestone Payment [Member] Developmental and regulatory milestone payment. Investments Investment, Policy [Policy Text Block] Share-based Payment Arrangement, Disclosure [Abstract] Share-Based Payment Arrangement, Disclosure [Abstract] Entity Current Reporting Status Entity Current Reporting Status Royalties receivable, period Collaborative Arrangement, Royalties Receivable, Period Collaborative Arrangement, Royalties Receivable, Period Contract with Customer, Contract Asset, Contract Liability, and Receivable Changes Contract with Customer, Contract Asset, Contract Liability, and Receivable Changes [Table Text Block] Contract with Customer, Contract Asset, Contract Liability, and Receivable Changes Options exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Thereafter Lessee, Operating Lease, Liability, to be Paid, After Year Four Lessee, Operating Lease, Liability, to be Paid, After Year Four Repayment of notes payable Repayments of Notes Payable Counterparty Name [Axis] Counterparty Name [Axis] Outstanding stock options (in shares) Awards outstanding, Beginning balance (in shares) Awards outstanding, Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Other Indication Other Indication [Member] Other indication. Capital stock, shares authorized (in shares) Common Stock And Preferred Stock Shares Authorized Common stock and preferred stock shares authorized. Notes receivable recorded at fair value Notes Assumed Schedule Of Stock By Class [Table] Schedule of Stock by Class [Table] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Sales / Repurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Property and equipment, net Property, Plant and Equipment, Net Percentage of non-voting economic interest of vTv Therapeutics Inc in vTv LLC Percentage Of Non Voting Economic Interest By Parent Percentage of non voting economic interest by parent. Issuance of Class A common stock under ATM offering Issuance Of Class A Common Stock Under ATM Offering Value Issuance Of Class A Common Stock Under ATM Offering Value Stock Option Common stock options granted under the Plan Share-Based Payment Arrangement, Option [Member] Maximum funding percentage of research and development milestones Maximum Funding Percentage Of Research And Development Milestones Maximum funding percentage of research and development milestones. Title of Individual Title of Individual [Domain] G2 Investments Purchase Agreement And Cogna Collaborative And License Agreement G2 Investments Purchase Agreement And Cogna Collaborative And License Agreement [Member] G2 Investments Purchase Agreement And Cogna Collaborative And License Agreement Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Other income (expense) Other Nonoperating Income (Expense) Sale of stock, price per share (in usd per shares) Sale of Stock, Price Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Schedule Of Related Party Transactions By Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Total operating expenses Operating Expenses Maximum Maximum [Member] Strategic Advisor Strategic Advisor [Member] Strategic advisor. Consideration received in advance and not recognized as revenue Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination Class A Common Stock Common Class A [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Contract liabilities Increase (Decrease) in Contract with Customer, Liability Total current assets Assets, Current Research and Development Arrangement, Contract to Perform for Others, Type Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Contract with customer, liability, revenue recognized Reclassification of the beginning contract liabilities to revenue, as the result of performance obligations satisfied Contract with Customer, Liability, Revenue Recognized Entity Small Business Entity Small Business Measurement Frequency Measurement Frequency [Domain] Stockholders' Deficit Stockholders' Equity Note Disclosure [Text Block] Weighted Average Exercise Price Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward] Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Exchange of Redeemable Non controlling Interest To Class A Common Stock Exchange Of Redeemable Non Controlling Interest To Class A Common Stock [Member] Exchange of redeemable non controlling interest to class A common stock. Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Current deposits Deposits Assets, Current Schedule Of Earnings Per Share [Table] Schedule Of Earnings Per Share [Table] Schedule Of Earnings Per Share [Table] Change from net loss attributable to vTv Therapeutics Inc. common shareholders and transfers to noncontrolling interest Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net Sales-based Milestones Payment Sales Based Milestones Payment [Member] Sales-based milestones payment. Accounts receivable Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security Master Service Agreement Master Service Agreement [Member] Master Service Agreement Aggregate offering price Aggregate Offering Price Of Shares Aggregate offering price of shares. Sale of stock, consideration, receivables, payment term Sale Of Stock, Consideration, Receivable, Term Sale Of Stock, Consideration, Receivable, Term Class Of Stock [Line Items] Class of Stock [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Present value of lease liabilities Operating Lease, Liability Expected volatility Measurement Input, Price Volatility [Member] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Summary of significant accounting policies. Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Minority Interest [Table] Noncontrolling Interest [Table] Liabilities, Redeemable Noncontrolling Interest and Stockholders’ Deficit Liabilities and Equity [Abstract] Granted (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Adjustments to transaction price for performance obligations Adjustments To Transaction Price For Performance Obligations Adjustments to transaction price for performance obligations. Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Percentage of non-voting economic interest of vTv Therapeutics Holdings LLC in vTv LLC Noncontrolling interest ownership percentage Percentage Of Non Voting Economic Interest Percentage of non voting economic interest. Sale of stock, consideration received on transaction Sale of Stock, Consideration Received on Transaction Unaudited Interim Financial Information Unaudited Interim Financial Information Policy [Policy Text Block] Unaudited interim financial information policy. Common stock warrants Warrant [Member] Entity Filer Category Entity Filer Category Proceeds from sale of Class A common stock, net of offering costs Net proceeds from issuance of common stock Proceeds from Issuance of Common Stock Weighted-average number of vTv Therapeutics Inc. Class A Common Stock, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Options vested and expected to vest (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price LPC Purchase Agreement L P C Purchase Agreement [Member] LPC purchase agreement. Total share-based compensation expense Share-Based Payment Arrangement, Expense Commitments and contingencies Commitments and Contingencies Security Exchange Name Security Exchange Name Awards outstanding, Beginning balance (in usd per share) Awards outstanding, Ending balance (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Customer Three Three Customers [Member] Three Customers Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Redeemable noncontrolling interest Beginning balance Ending balance Redeemable Noncontrolling Interest, Equity, Carrying Amount General and administrative General and Administrative Expense [Member] Share-based Payment Arrangement, Noncash Expense [Abstract] Share-Based Payment Arrangement, Noncash Expense [Abstract] Revenue Revenue from Contract with Customer, Excluding Assessed Tax Exchange of Class B common stock for class A common stock, shares (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Warrant liability, related party Warrant Liability Related Party [Member] Warrant liability, related party. Common stock, capital shares reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Cover [Abstract] Cover [Abstract] Letter Agreement Warrants Letter Agreement Warrants [Member] Letter agreement warrants. Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Shares held by related party (in shares) Investments in and Advances to Affiliates, Balance, Shares Share-Based Compensation Share-Based Payment Arrangement [Text Block] Increase in shares authorized (in shares) Increase In Common Stock Shares Authorized Increase in common stock shares authorized. Other income (expense) – related party Other Income Expenses Related Party The net amount of other related party income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. Customer One Customer One [Member] Customer One Redeemable Noncontrolling Interest Noncontrolling Interest [Member] Maximum contribution amount to clinical trial Maximum Sponsoring Contribution Amount Maximum sponsoring contribution amount. Cogna Cogna [Member] Cogna Total liabilities, redeemable noncontrolling interest and stockholders’ deficit Liabilities and Equity Public float Public Float Public float. Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Related Party Related Party [Axis] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Current Fiscal Year End Date Current Fiscal Year End Date Net loss attributable to common shareholders of vTv Therapeutics Inc., diluted Net Income (Loss) Available to Common Stockholders, Diluted Net loss per share of vTv Therapeutics Inc. Class A Common Stock, diluted (in usd per share) Earnings Per Share, Diluted Commitments And Contingencies [Table] Commitments And Contingencies [Table] Commitments And Contingencies [Table] Non-qualified stock option awards vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Royalties receivable, percent Collaborative Arrangement, Royalties Receivable, Percentage Collaborative Arrangement, Royalties Receivable, Percentage Share-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Concentration Risk Type Concentration Risk Type [Axis] Total current liabilities Liabilities, Current 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Net loss Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Customer Customer Concentration Risk [Member] License And Technology Transfer Services License And Technology Transfer Services [Member] License and technology transfer services. Unrecognized amount of transaction price allocated to performance obligation Revenue, Remaining Performance Obligation, Amount Non-qualified stock option awards expiration term Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Options vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Schedule of Maturities of Lease Liabilities for Operating Leases Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line One Entity Address, Address Line One Total contract liabilities Beginning balance Ending balance Contract with Customer, Liability Change in fair value of investments Change in fair value of investments Unrealized Gain (Loss) on Investments Product and Service Product and Service [Axis] Class of Stock Class of Stock [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Interest expense Interest Expense Deferred Revenue Disclosure [Abstract] Deferred Revenue Disclosure [Abstract] Maximum research funding receivable achievement based on research and development milestones Maximum Research Funding Receivable Based On Achievement Of Research And Development Milestones Maximum research funding receivable based on achievement of research and development milestones. License and Technology Transfer Services of Chemistry and Manufacturing Know-How License And Technology Transfer Services Of Chemistry And Manufacturing Know How [Member] License and technology transfer services of chemistry and manufacturing know-how. Equity Securities Without Readily Determinable Fair Value [Table] Equity Securities without Readily Determinable Fair Value [Table] Customers Two Two Customers [Member] Two Customers Equity [Abstract] Equity [Abstract] Entity Tax Identification Number Entity Tax Identification Number Due To Related Parties, Monthly Amount Due To Related Parties, Monthly Amount Due To Related Parties, Monthly Amount Promissory note receivable Notes Receivable, Current Notes Receivable, Current Revenue from Contract with Customer [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Remaining available stock value Remaining Availability Stock Issued During Period Value New Issues Remaining availability under our controlled equity offering sales agreement License Agreement Obligations License Agreement Obligations [Axis] License agreement obligations. Net increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Interest income Investment Income, Interest Measurement Frequency Measurement Frequency [Axis] Research and Development Research and Development Expense, Policy [Policy Text Block] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Collaboration Agreements Collaborative Arrangement Disclosure [Text Block] Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Hangzhou Zhongmei Huadong Pharmaceutical Company Limited [Member] Hangzhou Zhongmei Huadong Pharmaceutical Company Limited. Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Measurement Input Type Measurement Input Type [Axis] Entity Entity [Domain] City Area Code City Area Code General and administrative General and Administrative Expense Assets Assets [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Non-cash activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Weighted average grant date fair value of options granted (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Revenue recognized from change in estimated transaction prices Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Accounts and financing receivable, after allowance for credit loss Accounts and Financing Receivable, after Allowance for Credit Loss, Current Research and development Research and Development Expense [Member] Weighted Average Weighted Average [Member] Ownership percentage of majority owner Ownership Percentage Of Majority Owner Ownership percentage of majority owner. Reneo Reneo Pharmaceuticals Inc [Member] Reneo Pharmaceuticals Inc. Reconciliation of the Numerator and Denominator Used in the Calculation of Basic and Diluted Net Loss per Share of Class A Common Stock Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Conversion of Stock, Name Conversion of Stock, Name [Domain] Description of Business, Basis of Presentation and Going Concern Business Description and Basis of Presentation [Text Block] Customer [Domain] Customer [Domain]